pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

2,916 catalysts · 3,288 8k filing · 2,435 grant · 2,379 approval · 1,691 device 510k · 1,229 device recall · 1,158 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: recall×type: grant×from 2025-10-01×clear all
type
  • 8k filing3,288
  • grant2,435
  • approval2,379
  • device 510k1,691
  • device recall1,229
  • device pma1,158
device adverse event
1,000
  • earnings584
  • recall481
  • phase 2 completion172
  • therapy area

    no tagged catalysts yet

    Week of Sep 29, 2025

    49
    ›Oct 1, 2025recall317d agoGlenmark Pharmaceuticals Inc., USA recall (Cls II)LB PHARMACEUTICALS INC

    Azelaic Acid Gel, 15%, 50 grams, For Topical Use Only, Rx only, Manufactured by: Glenmark Pharmaceuticals Limited Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-626-52 — Reason: CGMP Deviations: Market complaints received for gritty texture (grainy) — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 1, 2025recall317d agoPrivate Label Skin Care Inc. recall (Cls II)Galderma Laboratories LP

    edunn clarity, BP Treatment Cleanser 10% (Benzoyl Peroxide 10%), 7 oz (201g) Uptown Medi Spa, Phoenix, AZ. — Reason: Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products. — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 1, 2025recall317d agoConsumer Product Partners, LLC recall (Cls III)KROGER CO

    TopCare Health 70% Isopropyl Alcohol, NET WT 5.5 OZ (156 g) per can, Distributed By The KROGER CO., Cincinnati, Ohio 45202. NDC: 36800-589-14 — Reason: Cross Contamination with Other Products. — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 1, 2025recall317d agoConsumer Product Partners, LLC recall (Cls III)KROGER CO

    Kroger 70% Isopropyl Alcohol, NET WT 5.5 OZ (156 g) per can, Distributed By The KROGER CO., Cincinnati, Ohio 45202. NDC: 30142-810-14 — Reason: Cross Contamination with Other Products. — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 1, 2025recall317d agoPrivate Label Skin Care Inc. recall (Cls II)Galderma Laboratories LP

    ARTISAN OF SKIN (Benzoyl Peroxide 10%) , 7 oz (201 g), Artisan of Skin Beverly Hills, CA 90210 — Reason: Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products. — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 1, 2025recall317d agoGranules Pharmaceuticals Inc. recall (Cls III)LB PHARMACEUTICALS INC

    Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 20 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-032-01 — Reason: Failed Impurities/Degradation Specifications: — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 1, 2025recall317d agoGranules Pharmaceuticals Inc. recall (Cls III)LB PHARMACEUTICALS INC

    Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 10 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-030-01 — Reason: Failed Impurities/Degradation Specifications: — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 1, 2025recall317d agoPrivate Label Skin Care Inc. recall (Cls II)Galderma Laboratories LP

    mel rx Skin, NO DRAMA Benzoyl Peroxide 10% Acne Treatment, 7 oz, 201 g Mel Skin Rx Beverly Hills, CA 90210 — Reason: Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products. — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 1, 2025recall317d agoGranules Pharmaceuticals Inc. recall (Cls III)LB PHARMACEUTICALS INC

    Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 5 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-029-01 — Reason: Failed Impurities/Degradation Specifications: — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 1, 2025recall317d agoGranules Pharmaceuticals Inc. recall (Cls III)LB PHARMACEUTICALS INC

    Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 15 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-031-01 — Reason: Failed Impurities/Degradation Specifications: — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 1, 2025recall317d agoPrivate Label Skin Care Inc. recall (Cls II)Galderma Laboratories LP

    Micronized BPO Gel Cleanser 10% (Benzoyl Peroxide 10%) Pantea MD , 7 oz (201 g), University Skin Institute, 650 University Ave, Ste 200, Sacramento, CA 95825. — Reason: Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products. — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 1, 2025recall317d agoMedline Industries, LP recall (Cls III)

    READYPREP PVP, Povidone-Iodine 10% Solution, Topical Antiseptic, Not Sterile, 1 Gallon (3.78 L) per bottle, Manufactured in USA by Medline Industries, LP., Three Lakes Drive, Northfield, IL 60093, NDC 53329-939-25 — Reason: Subpotent drug — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 1, 2025recall317d agoPrivate Label Skin Care Inc. recall (Cls II)Galderma Laboratories LP

    Skin MD by Dr Monika Kiripolsky, Body Acne Cleanser (Benzoyl Peroxide 10%), 7 oz (201 g), Monika Kiripolsky, MD Beverly Hills, CA, 90211 — Reason: Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products. — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 1, 2025recall317d agoPrivate Label Skin Care Inc. recall (Cls II)Galderma Laboratories LP

    Torrey Pines Dermatology & Laser Center Benzaderm BPO Cleanser 10% (Benzoyl Peroxide 10%) 7oz (201 g), Torreypines.com — Reason: Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products. — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 1, 2025recall317d agoGranules Pharmaceuticals Inc. recall (Cls III)LB PHARMACEUTICALS INC

    Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 30 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-034-01 — Reason: Failed Impurities/Degradation Specifications: — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 1, 2025recall317d agoYANGZHOU YULOU PAPER PRODUCTS CO., LTD recall (Cls II)

    Quick Touch Alcohol Prep Pads(Isopropyl Alcohol 70%), 100 Sterile Pads per carton, AUM Pharmaceuticals, 320 Oser Ave., Hauppauge, NY 11788. — Reason: cGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 1, 2025grant317d agoRLR VA MEDICAL CENTER — Boosting employment to improve health and recovery among Veterans in substanc...

    VA grant. PI: Alan Benjamin McGuire

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoLOUIS STOKES CLEVELAND VA MEDICAL CENTER — Ancestry-Specific Genetic Influences and Potential Therapeutics for Ocular Di...

    VA grant. PI: NEAL S. PEACHEY

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoVA PUGET SOUND HEALTHCARE SYSTEM — Determining Optimal Foot Shape Capture Methods to Prioritize Offloading in An...

    VA grant. PI: Brittney C Muir

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoLOUIS STOKES CLEVELAND VA MEDICAL CENTER — Optimizing deep brain stimulation to improve visuomotor function in Parkinson...

    VA grant. PI: Aasef G Shaikh

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoVETERANS HEALTH ADMINISTRATION — Mapping Phenotypes in Abdominal Aortic Aneurysms

    VA grant. PI: JOHN A CURCI

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoVA SAN DIEGO HEALTHCARE SYSTEM — “Neural Stem Cells for Spinal Cord Injury: Studies leading to an IND”

    VA grant. PI: MARK H. TUSZYNSKI

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoFLORIDA STATE UNIVERSITY — Experimental evaluation of the mechanisms driving acute stress potentiation o...

    DA grant. $150,505. PI: Richard Macatee

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoVETERANS HEALTH ADMINISTRATION — Testing the Impact of Measurement-Based Care on Quality of Life and DiseaseMa...

    VA grant. PI: Shirley Ann Cohen-Mekelburg

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoVETERANS ADMIN PALO ALTO HEALTH CARE SYS — A Mobile Health Intervention to Improve Psychosocial Functioning in Veterans ...

    VA grant. PI: Haijing Wu Hallenbeck

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoWHITE RIVER JUNCTION VA MEDICAL CENTER — Suicide prevention in Department of Veterans Affairs community care network m...

    VA grant. PI: Natalie Riblet

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoVA NORTHERN CALIFORNIA HEALTH CARE SYS — Driving Simulator Training to Improve Driving Performance in Veteran Stroke P...

    VA grant. PI: Juliana V. Baldo

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoVA MEDICAL CENTER — Virtual Care Consortium of Research (VC CORE) - COR-20-199

    VA grant. PI: Timothy Patrick Hogan

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoVETERANS HEALTH ADMINISTRATION — iTBS Therapy for Alleviating Cognitive Deficits after Traumatic Brain Injury

    VA grant. PI: Nicole Michelle Weston

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoRLR VA MEDICAL CENTER — Protective pathways in sepsis-induced renal injury

    VA grant. PI: Takashi Hato

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoDARTMOUTH COLLEGE — Rapid innovation of precision psychiatry interventions using dynamic systems ...

    OD grant. $408,750. PI: Emily Kelley Presseller

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoVA SAN DIEGO HEALTHCARE SYSTEM — Enhancing Veteran-Clinical Collaboration in VA Psychosocial Rehabilitation an...

    VA grant. PI: Emily Treichler

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoNEW YORK UNIVERSITY — Addressing the Research Capacity Gap in Global Child, Adolescent, & Family He...New York University

    TW grant. $164,984. PI: Theresa Stichick Betancourt

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoNORTHAMPTON VA MEDICAL CENTER — Re-animation of the eye with neodymium actuation system

    VA grant. PI: Kevin Edward Houston

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoVA PUGET SOUND HEALTHCARE SYSTEM — Integrative genomic and environmental study to understand central sensitizati...

    VA grant. PI: Marianna Gasperi

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoLOUIS STOKES CLEVELAND VA MEDICAL CENTER — Development of FES+BMI Neuroprosthesis for At-Home Use for Persons with Chron...

    VA grant. PI: ABIDEMI BOLU AJIBOYE

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoMIAMI VA HEALTH CARE SYSTEM — Epigenetic and metabolic mechanisms of cadmium cytotoxicity

    VA grant. PI: David Benner Lombard

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoRALPH H JOHNSON VA MEDICAL CENTER — Role of central amygdala dynorphin neurons in mediating chronic alcohol induc...

    VA grant. PI: Christina Lebonville

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoRLR VA MEDICAL CENTER — Mechanisms of physioxia-dependent cancer cell adaptation to targeted drugs al...

    VA grant. PI: Harikrishna Nakshatri

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoDURHAM VA MEDICAL CENTER — Using Community Health Workers to Support Rural Care Partners of Seriously Il...

    VA grant. PI: Nathan Adam Boucher

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoOLIN TEAGUE VETERANS CENTER — A Randomized Controlled Trial of a Web-Based Moral Elevation Intervention for...

    VA grant. PI: Adam Patrick McGuire

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoEDWARD HINES JR VA HOSPITAL — Biomarkers for Recovery of Veterans with Severe Spinal Cord Injury

    VA grant. PI: Monica A Perez

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoVETERANS AFFAIRS MED CTR SAN FRANCISCO — Post-Hospitalization Virtual Care Among Veterans with Heart Failure: Examinin...

    VA grant. PI: Charlie M Wray

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoEDITH NOURSE ROGERS MEMORIAL VETERANS HOSPITAL — The Development of a Transdiagnostic Intervention to Improve Social Functioni...

    VA grant. PI: Hannah Grigorian

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoRLR VA MEDICAL CENTER — Developing a patient-centered intervention to improve exercise adoption and a...

    VA grant. PI: Sarah Shue

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoPORTLAND VA MEDICAL CENTER — Exploring the Role of Central Auditory Processing in Spoken Language Comprehe...

    VA grant. PI: Marianne E Casilio

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoPORTLAND VA MEDICAL CENTER — Glymphatics Imaging to Probe Sleep in Veterans with the Polytrauma Clinical T...

    VA grant. PI: Jonathan E Elliott

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoST. LOUIS VA MEDICAL CENTER — Long-term Cardiometabolic Disease in COVID-19

    VA grant. PI: Ziyad Al-Aly

    full page →nih reporter ↗
    ›Oct 1, 2025grant317d agoUTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH — Innate Immunity to Viral Infection of the RetinaUniversity of Utah

    EY grant. $199,749. PI: Christopher Dale Conrady

    full page →nih reporter ↗

    Week of Oct 6, 2025

    1
    ›Oct 8, 2025recall310d agoZydus Pharmaceuticals (USA) Inc recall (Cls II)LB PHARMACEUTICALS INC

    Entecavir Tablets, USP, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06. — Reason: Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity — Status: Ongoing

    full page →fda recalls ↗
    ← prev
    page 1 of 59
    next →
    $LBRX44.27-2.45%
    $KR
    $KR
    $LBRX44.27-2.45%
    $LBRX44.27-2.45%
    $LBRX44.27-2.45%
    $LBRX44.27-2.45%
    $LBRX44.27-2.45%
    $LBRX44.27-2.45%